3 No-Brainer Biotech Stocks to Buy in November
Some investing decisions are really hard to make. Others, though, can be quick and easy. That's the case when the stocks offer compelling growth prospects that are undeniable.
We asked three Motley Fool contributors to pick no-brainer biotech stocks to buy in November. Here's why they chose Bristol Myers Squibb (NYSE: BMY), Exelixis (NASDAQ: EXEL), and Vertex Pharmaceuticals (NASDAQ: VRTX).
Source Fool.com